Published in J Immunol on October 20, 2010
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front Cell Neurosci (2013) 1.65
Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegeneration. Front Pharmacol (2012) 1.20
MFG-E8 mediates primary phagocytosis of viable neurons during neuroinflammation. J Neurosci (2012) 1.17
Neuronal death induced by nanomolar amyloid β is mediated by primary phagocytosis of neurons by microglia. J Biol Chem (2011) 1.17
Microglia function in Alzheimer's disease. Front Pharmacol (2012) 1.17
Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc Natl Acad Sci U S A (2012) 1.01
Transcriptome-wide survey of mouse CNS-derived cells reveals monoallelic expression within novel gene families. PLoS One (2012) 1.00
Prolonged gaseous hypothermia prevents the upregulation of phagocytosis-specific protein annexin 1 and causes low-amplitude EEG activity in the aged rat brain after cerebral ischemia. J Cereb Blood Flow Metab (2012) 0.99
Ontogeny and functions of central nervous system macrophages. J Immunol (2014) 0.96
Sex differences in Parkinson's disease. Front Neuroendocrinol (2014) 0.92
Sweepers in the CNS: Microglial Migration and Phagocytosis in the Alzheimer Disease Pathogenesis. Int J Alzheimers Dis (2012) 0.88
Effect of aging on islet beta-cell function and its mechanisms in Wistar rats. Age (Dordr) (2011) 0.85
The Proteome of Native Adult Müller Glial Cells From Murine Retina. Mol Cell Proteomics (2015) 0.85
Annexin A1 and the Resolution of Inflammation: Modulation of Neutrophil Recruitment, Apoptosis, and Clearance. J Immunol Res (2016) 0.83
An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease. Alzheimers Res Ther (2016) 0.78
Activated microglia cause reversible apoptosis of pheochromocytoma cells, inducing their cell death by phagocytosis. J Cell Sci (2015) 0.78
Evaluation of CRRT effects on pyemic secondary AKI by serum cartilage glycoprotein 39 and Annexin A1. Exp Ther Med (2016) 0.77
Effect of acute stressor and serotonin transporter genotype on amygdala first wave transcriptome in mice. PLoS One (2013) 0.77
Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation. J Immunol (2015) 0.77
Recurrent duplications of the annexin A1 gene (ANXA1) in autism spectrum disorders. Mol Autism (2014) 0.77
The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide. J Neuroinflammation (2016) 0.76
Annexin A1 translocates to nucleus and promotes the expression of pro-inflammatory cytokines in a PKC-dependent manner after OGD/R. Sci Rep (2016) 0.76
Sex-specific disruption of murine midbrain astrocytic and dopaminergic developmental trajectories following antenatal GC treatment. Brain Struct Funct (2015) 0.76
Annexin A1 restores Aβ1-42 -induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway. Aging Cell (2016) 0.76
Validation of Flow Cytometry and Magnetic Bead-Based Methods to Enrich CNS Single Cell Suspensions for Quiescent Microglia. J Neuroimmune Pharmacol (2015) 0.76
The restorative role of annexin A1 at the blood-brain barrier. Fluids Barriers CNS (2016) 0.75
Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease. Front Endocrinol (Lausanne) (2011) 0.75
The Role and Effects of ANXA1 in Temporal Lobe Epilepsy: A Protection Mechanism? Med Sci Monit Basic Res (2015) 0.75
Genome-wide pathway analysis of a genome-wide association study on Alzheimer's disease. Neurol Sci (2014) 0.75
The involvement of xanthohumol in the expression of annexin in human malignant glioblastoma cells. Open Biochem J (2013) 0.75
Annexin-1 Mediates Microglial Activation and Migration via the CK2 Pathway during Oxygen-Glucose Deprivation/Reperfusion. Int J Mol Sci (2016) 0.75
Sex differences in microglial phagocytosis in the neonatal hippocampus. Brain Behav Immun (2017) 0.75
The Pathophysiological Role of Microglia in Dynamic Surveillance, Phagocytosis and Structural Remodeling of the Developing CNS. Front Mol Neurosci (2017) 0.75
The hypothesis that Helicobacter pylori predisposes to Alzheimer's disease is biologically plausible. Sci Rep (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A (1976) 21.06
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science (2005) 14.43
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol (1992) 11.24
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest (1989) 7.60
Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol (2009) 6.79
Microglia in neurodegenerative disease. Nat Rev Neurol (2010) 5.83
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience (1990) 4.52
Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol (1990) 4.37
Clearance of apoptotic cells: getting rid of the corpses. Mol Cell (2004) 3.64
Regulation of innate immune responses in the brain. Nat Rev Immunol (2009) 3.41
Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol (2009) 3.32
Short-term and long-term survival of new neurons in the rat dentate gyrus. J Comp Neurol (2003) 3.01
Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med (2002) 2.75
Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev (2006) 2.57
Microglia biology in health and disease. J Neuroimmune Pharmacol (2006) 2.53
Signaling in adult neurogenesis. Annu Rev Cell Dev Biol (2009) 2.47
Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol (2010) 2.43
Inflammation and neurodegeneration in Parkinson's disease. Parkinsonism Relat Disord (2004) 2.41
The annexins. Genome Biol (2004) 2.07
The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX (2009) 1.97
Annexin 1: more than an anti-phospholipase protein. Inflamm Res (2004) 1.90
Microglial clearance function in health and disease. Neuroscience (2008) 1.84
LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. Brain (2005) 1.81
Characterization of Ca2(+)-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem J (1990) 1.71
Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasone-treated macrophages and annexin-derived peptide Ac(2-26). J Immunol (2005) 1.68
Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol Cell Neurosci (2000) 1.66
Apoptosis: the importance of being eaten. Cell Death Differ (1998) 1.65
Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol (2006) 1.62
Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood (2005) 1.62
Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: effect of lipocortin 1. Proc Natl Acad Sci U S A (1998) 1.60
Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol (2007) 1.59
Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease. J Immunol (2008) 1.47
Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications. Apoptosis (2008) 1.42
A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J (2003) 1.30
Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study. Histochem Cell Biol (1998) 1.26
Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J Leukoc Biol (2002) 1.26
Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A (1994) 1.23
Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J (2006) 1.21
Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1. Cell Growth Differ (1998) 1.20
Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid. J Biol Chem (2005) 1.18
Development of a culture system that supports adult microglial cell proliferation and maintenance in the resting state. J Immunol Methods (2005) 1.18
Microglial phagocytosis of apoptotic inflammatory T cells leads to down-regulation of microglial immune activation. J Immunol (2001) 1.18
Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation (2007) 1.17
Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J Biol Chem (2001) 1.17
Phagocytic clearance of apoptotic neurons by Microglia/Brain macrophages in vitro: involvement of lectin-, integrin-, and phosphatidylserine-mediated recognition. J Neurochem (2000) 1.14
Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol (2004) 1.14
X-ray structure of full-length annexin 1 and implications for membrane aggregation. J Mol Biol (2001) 1.14
Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur J Pharmacol (1995) 1.11
Optimized isolation enables ex vivo analysis of microglia from various central nervous system regions. Glia (2007) 1.08
Monoclonal antibodies to lipocortin-1 as probes for biological function. FEBS Lett (1990) 1.06
Annexin 1 binds to U937 monocytic cells and inhibits their adhesion to microvascular endothelium: involvement of the alpha 4 beta 1 integrin. J Immunol (2000) 1.02
Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells. J Immunol (2002) 1.00
Annexin A1 in the brain--undiscovered roles? Trends Pharmacol Sci (2008) 1.00
Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1-42-induced signal transduction in glial cells. J Neurochem (2010) 0.99
Cytokine modulation of liver annexin 1 expression during experimental endotoxemia. Am J Pathol (2001) 0.99
Multiple sclerosis: a battle between destruction and repair. J Neurochem (2006) 0.99
Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation. Am J Pathol (2008) 0.99
Neuronal apoptotic bodies: phagocytosis and degradation by primary microglial cells. FASEB J (2004) 0.98
Classification of amyloidosis: misdiagnosing by way of incomplete immunohistochemistry and how to prevent it. Acta Histochem (2006) 0.97
U937 cells deprived of endogenous annexin 1 demonstrate an increased PLA2 activity. Br J Pharmacol (1998) 0.95
Neuronal expression of Cd36, Cd44, and Cd83 antigen transcripts maps to distinct and specific murine brain circuits. J Comp Neurol (2009) 0.94
Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulated adrenal function. J Clin Endocrinol Metab (2004) 0.92
Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization. FASEB J (2009) 0.89
Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides. FASEB J (2007) 0.88
Immunohistochemical localization of lipocortin 1 in rat brain is sensitive to pH, freezing, and dehydration. J Histochem Cytochem (1997) 0.87
Evidence from studies on co-cultures of TtT/GF and AtT20 cells that Annexin 1 acts as a paracrine or juxtacrine mediator of the early inhibitory effects of glucocorticoids on ACTH release. J Neuroendocrinol (2003) 0.85
Expression of annexin-1 in multiple sclerosis plaques. Neuropathol Appl Neurobiol (2002) 0.84
6-hydroxydopamine-induced nuclear factor-kappa B activation in PC12 cells. Biochem Pharmacol (2001) 0.78
Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med (2002) 2.75
LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum Mol Genet (2009) 2.55
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain (2011) 2.06
Annexin 1: more than an anti-phospholipase protein. Inflamm Res (2004) 1.90
Evaluation of alpha-synuclein immunohistochemical methods used by invited experts. Acta Neuropathol (2008) 1.81
Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J Nucl Med (2007) 1.76
A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol (2010) 1.69
Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement. Blood (2005) 1.62
Presynaptic NMDARs in the hippocampus facilitate transmitter release at theta frequency. Neuron (2010) 1.33
Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol (2009) 1.32
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain (2012) 1.27
The neuropathological basis of clinical progression in multiple sclerosis. Acta Neuropathol (2011) 1.14
Attenuation of glucocorticoid functions in an Anx-A1-/- cell line. Biochem J (2003) 1.11
Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease. J Nucl Med (2008) 1.10
Lesionectomy in epileptogenic gangliogliomas: seizure outcome and surgical results. J Clin Neurosci (2006) 1.10
Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice. Endocrinology (2003) 1.05
Mycobacterium tuberculosis upregulates microglial matrix metalloproteinase-1 and -3 expression and secretion via NF-kappaB- and Activator Protein-1-dependent monocyte networks. J Immunol (2010) 1.05
Acetylcholine receptor antibodies in patients with genetic myopathies: clinical and biological significance. Neuromuscul Disord (2011) 1.01
Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc Natl Acad Sci U S A (2012) 1.01
Annexin A1 in the brain--undiscovered roles? Trends Pharmacol Sci (2008) 1.00
Role of Annexin A1 in mouse myoblast cell differentiation. J Cell Physiol (2010) 1.00
Existence of long-lasting experience-dependent plasticity in endocrine cell networks. Nat Commun (2012) 0.99
Annexin 1, glucocorticoids, and the neuroendocrine-immune interface. Ann N Y Acad Sci (2006) 0.97
Chromosomal profiles of gene expression in Huntington's disease. Brain (2007) 0.97
Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585. Eur J Hum Genet (2012) 0.96
Annexin 1 and the regulation of endocrine function. Trends Endocrinol Metab (2004) 0.96
Intraosseous angiolipoma of the cranium: case report. Neurosurgery (2009) 0.95
Cortical ependymoma: an unusual epileptogenic lesion. J Neurosurg (2011) 0.94
Nineteen-year follow-up of Waldenström's-associated neuropathy and Bing-Neel syndrome. Muscle Nerve (2009) 0.94
Cellular in vivo imaging reveals coordinated regulation of pituitary microcirculation and GH cell network function. Proc Natl Acad Sci U S A (2010) 0.94
Antiallergic cromones inhibit neutrophil recruitment onto vascular endothelium via annexin-A1 mobilization. Arterioscler Thromb Vasc Biol (2010) 0.94
The size and distribution of midbrain dopaminergic populations are permanently altered by perinatal glucocorticoid exposure in a sex- region- and time-specific manner. Neuropsychopharmacology (2006) 0.93
Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulated adrenal function. J Clin Endocrinol Metab (2004) 0.92
Annexin 1-dependent actions of glucocorticoids in the anterior pituitary gland: roles of the N-terminal domain and protein kinase C. Endocrinology (2002) 0.92
Expression, subcellular localization and phosphorylation status of annexins 1 and 5 in human pituitary adenomas and a growth hormone-secreting carcinoma. Clin Endocrinol (Oxf) (2004) 0.92
Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle. Neuroreport (2003) 0.91
Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study. Acta Neuropathol (2012) 0.90
Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort. J Clin Endocrinol Metab (2014) 0.90
Annexin A1 regulates hormone exocytosis through a mechanism involving actin reorganization. FASEB J (2009) 0.89
Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1. Biochem Pharmacol (2009) 0.89
Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition. J Neurochem (2006) 0.89
Levels of p27 sensitize to dual PI3K/mTOR inhibition. Mol Cancer Ther (2011) 0.88
Chromosomal patterns of gene expression from microarray data: methodology, validation and clinical relevance in gliomas. BMC Bioinformatics (2006) 0.88
Three redox states of nitrosyl: NO+, NO*, and NO-/HNO interconvert reversibly on the same pentacyanoferrate(II) platform. Angew Chem Int Ed Engl (2009) 0.87
Gene deletion reveals roles for annexin A1 in the regulation of lipolysis and IL-6 release in epididymal adipose tissue. Am J Physiol Endocrinol Metab (2006) 0.87
Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro. J Immunol (2013) 0.87
Leptomeningeal hemangioblastoma. Case illustration. J Neurosurg (2004) 0.87
Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers. J Clin Endocrinol Metab (2015) 0.86
Annexin 1: a paracrine/juxtacrine mediator of glucorticoid action in the neuroendocrine system. Cell Biochem Funct (2003) 0.86
Loss of PDCD4 contributes to enhanced chemoresistance in Glioblastoma multiforme through de-repression of Bcl-xL translation. Oncotarget (2013) 0.86
Different degrees of somatotroph ablation compromise pituitary growth hormone cell network structure and other pituitary endocrine cell types. Endocrinology (2009) 0.86
Dexamethasone enhances interaction of endogenous annexin 1 with L-selectin and triggers shedding of L-selectin in the monocytic cell line U-937. Br J Pharmacol (2003) 0.86
[¹¹C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches. Eur J Nucl Med Mol Imaging (2013) 0.85
Mycobacterium tuberculosis-infected human monocytes down-regulate microglial MMP-2 secretion in CNS tuberculosis via TNFα, NFκB, p38 and caspase 8 dependent pathways. J Neuroinflammation (2011) 0.85
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol (2012) 0.84
Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neurones. J Physiol (2003) 0.84
Corticotroph adenoma of the pituitary in a patient with X-linked adrenal hypoplasia congenita due to a novel mutation of the DAX-1 gene. Eur J Endocrinol (2005) 0.84
The LGI1/epitempin gene encodes two protein isoforms differentially expressed in human brain. J Neurochem (2006) 0.84
The lack of expression of the peripheral benzodiazepine receptor characterises microglial response in anaplastic astrocytomas. J Neurooncol (2007) 0.84
Annexin 1 modulates monocyte-endothelial cell interaction in vitro and cell migration in vivo in the human SCID mouse transplantation model. J Immunol (2002) 0.84
A case of primary leptomeningeal gliomatosis confined to the spinal cord. J Neurooncol (2009) 0.84
Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas. Acta Neuropathol (2013) 0.83
Insulin and IGF-I inhibit GH synthesis and release in vitro and in vivo by separate mechanisms. Endocrinology (2013) 0.83
Tolosa-Hunt syndrome due to actinomycosis of the cavernous sinus: the infectious hypothesis revisited. Headache (2004) 0.83
Galectin-3 expression is ubiquitous in tumors of the sellar region, nervous system, and mimics: an immunohistochemical and RT-PCR study. Am J Surg Pathol (2008) 0.83
Ectopic TSH-secreting pituitary adenoma of the vomerosphenoidal junction. Eur J Endocrinol (2003) 0.83
Amyloidoma of the brachial plexus. Surg Neurol (2003) 0.83
Primary glial tumor of the retina with features of myxopapillary ependymoma. Am J Surg Pathol (2005) 0.82
Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1. PLoS One (2013) 0.82
Membrane-induced folding and structure of membrane-bound annexin A1 N-terminal peptides: implications for annexin-induced membrane aggregation. Biophys J (2007) 0.82
Novel ontogenetic patterns of sexual differentiation in arcuate nucleus GHRH neurons revealed in GHRH-enhanced green fluorescent protein transgenic mice. Endocrinology (2010) 0.82
P53 gene mutations in pituitary carcinomas. Endocr Pathol (2007) 0.82
Antiflammin-2 activates the human formyl-peptide receptor like 1. ScientificWorldJournal (2006) 0.81
Mean Expression of the X-Chromosome is Associated with Neuronal Density. Front Neurosci (2012) 0.81
Intracerebral multifocal Rosai-Dorfman disease. J Clin Neurosci (2012) 0.81
Cerebral coenurosis. Case illustration. J Neurosurg (2004) 0.80
Primary sellar neuroblastoma presenting with syndrome of inappropriate secretion of anti-diuretic hormone. Endocr Pathol (2010) 0.80
In vitro and in vivo studies on CCR10 regulation by Annexin A1. FEBS Lett (2006) 0.79
Oligodendrocyte gap junction loss and disconnection from reactive astrocytes in multiple sclerosis gray matter. J Neuropathol Exp Neurol (2014) 0.79
Reactivity of reduced nitroprusside, [Fe(CN)5NO*]3-, toward oxygen. J Am Chem Soc (2007) 0.79
Spinal extradural solitary fibrous tumor with retiform and papillary features. Ann Diagn Pathol (2013) 0.77
The [Ru(Hedta)NO](0.1-) system: structure, chemical reactivity and biological assays. J Inorg Biochem (2004) 0.77
October 2006: a 37-year old male with headache. Brain Pathol (2007) 0.77
Anti-allergic drugs and the Annexin-A1 system. Pharmacol Rep (2010) 0.76
Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly? J Clin Endocrinol Metab (2013) 0.76
Intra-operative, real-time, three-dimensional ultrasound assisted positioning of catheters in the microdialysis of glial tumours. J Clin Neurosci (2010) 0.76
Schwannoma with small cell component. Virchows Arch (2003) 0.76
Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease. Front Endocrinol (Lausanne) (2011) 0.75
Spinal cord compression due to an extra-dural intra-vascular papillary endothelial hyperplasia of the thoracic spine. Acta Neurochir (Wien) (2009) 0.75
Redox properties of ruthenium nitrosyl porphyrin complexes with different axial ligation: structural, spectroelectrochemical (IR, UV-visible, and EPR), and theoretical studies. Inorg Chem (2008) 0.75
Painful myositis in the anti-synthetase syndrome with anti-PL12 antibodies. Rheumatol Int (2011) 0.75
Middle meningeal artery hemorrhage: an incorrect name. Clin Anat (2007) 0.75
Muslin granuloma presenting with speech disturbance diagnosed by endoscopic biopsy. Acta Neurochir (Wien) (2009) 0.75